As shown in Figure 9D–F, MAPK4 expression was significantly positively correlated with expression of the main immunoinhibitory checkpoint molecules PD‐1, PD‐L1, HAVCR2, PDCD1LG2 and TIGIT in glioma. Here, PDCD1 is linked to central nervous system cancer.